Involvement of proteases in the action of IFN-γ on WISH cells

Journal of Interferon and Cytokine Research

Volumn 22, Issue 8, 2002, Pages 847-852

  Aharon, Miri ^a   Dvilansky, Alexander ^a   Shpilberg, Ofer ^a   Nathan, Ilana ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASPARTIC ACID; BENZYLSULFONYL FLUORIDE; CHYMOTRYPSIN; CYSTINE; EDETIC ACID; GAMMA INTERFERON; GELATIN; LEUPEPTIN; METALLOPROTEINASE; PEPSTATIN; PROTEINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SOYBEAN TRYPSIN INHIBITOR; THIORPHAN; THYMIDINE; TOSYLLYSYL CHLOROMETHYL KETONE; TRYPSIN;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL STRAIN; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; ELECTROPHORESIS; ENZYME SUBSTRATE COMPLEX; HORMONE ACTION; INHIBITION KINETICS; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINASE INHIBITION;

AMNION; CELL DIVISION; CELL LINE; CELL MEMBRANE; DNA REPLICATION; HUMANS; INTERFERON TYPE II; LEUPEPTINS; LYSINE; PEPSTATINS; PHENYLALANINE; PHENYLMETHYLSULFONYL FLUORIDE; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SUBCELLULAR FRACTIONS; THIORPHAN; TOSYLLYSINE CHLOROMETHYL KETONE; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

ANIMALIA; GLYCINE MAX;

EID: 0036407346     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999002760274854     Document Type: Article

References (31)

1. + T cell hybridomas by human mast cells through superantigen presentation. J. Leukocyte Biol. 66, 105-112.
2. Blum, J.S., and Creswell, P. (1988). Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85, 3975-3979.
3. Smith, B., Merlin, G., and Berman, B. (1991). Induction of HLA-DR antigen expression on human skin cells. Exp. Cell Res. 183, 215-228.
4. Budnik, A., Grewe, M., Gyufko, K., and Krutmann, J. (1996). Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hema and the 24 kDa apoptotic protease (AP24). FASEB J. 10, 352-359.
5. Kooy, A.J., Prens, E.P., Van-Heukelum, A., Vuzevski, V.D., Van-Joost, T., and Tank, B. (1999). Interferon gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10? J. Pathol. 187, 355-357.
6. Deiss, L.P., Feinstein, E., Berissi, H., Cohen, O., and Kimchi, A. (1995). Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma-interferon-induced cell death. Genes Dev. 9, 15-30.
7. Takahashi, H., Nakamura, S., Asano, K., Kinouchi, N., Ishida-Yamamoto, A., and Iizuka, H. (1999). Fas antigen modulates ultraviolet B-induced apoptosis of SVHK cells: sequential activation of caspases 8, 3, and 1 in the apoptotic process. Exp. Cell Res. 249, 291-298.
8. Dai, C., and Krantz, S.B. (1999). Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93, 3309-3316.
9. Feng, B., and Denhardt, D.T. (1992). Inhibition of the primary transcript of the gene encoding tissue inhibitor of metalloproteinases (TIMP) by antisense TIMP RNA in mouse 3T3 cells. Ann. NY Acad Sci. 660, 280-282.
10. Tchorzewski, H., Fornalczyk, E., and Pasnik, J. (1995). Protease inhibitors diminish lymphocyte stimulation in vitro. Immunol. Lett. 46, 237-240.
11. Aharon, M., Ben Valid, I., Dvilansky, A., and Nathan, I. (1995). TPK inhibitors differentially affected IFN-γ activities. Anticancer Res. 15, 2071-2076.
12. Orchansky, P., Rubinstein, M., and Fischer, D.G. (1986). The interferon γ receptor in human monocytes is different from the one in nonhematopoietic cells. J. Immunol. 136, 169-173.
13. Bourgeade, M.F., Silberman, F., Thang, M.N., and Betrypsin-Sançon, F. (1988). Reduction of transferin receptor expression by interferon gamma in a human cell line sensitive to its antiproliferative effect. Biochem. Biophys. Res. Commun. 153, 897-903.
14. Sharoni, Y., Bosin, E., Minster, A., Levy, J., and Schally, A.V. (1989). Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 86, 1648-1651.
15. Piga, A., Taheri, M.R., Yaxley, J.C., Wickremasunghe, R.G., and Hoffbrand, A.V. (1984). Higher tyrosine protein kinase activity in resting lymphocytes than in proliferating normal or leukemic blood cells. Biochem. Biophys. Res. Commun. 124, 766-773.
16. Bradford, M.A. (1976). A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-255.
17. Green, G.D.J., and Shaw, E. (1979). Thiobenzyl benzyloxy carbonyl-L-lysinate substrate for a sensitive colorimetric assay for trypsine-like enzymes. Anal. Biochem. 93, 223-226.
18. Hummel, B.C.W. (1959). A modified spectrophotometric assay determination of chymotrypsin trypsin and thrombin. Can. J. Biochem. Physiol. 37, 1393.
19. Distefano, J.F., Cotto, C.A., Lane, B., and Hagag, N. (1988). Oncogene ras p21 and v-src pp60-transformed cells exhibit altered expression of proteases. Cancer Invest. 6, 487-498.
20. Hill, G.E., Springll, D.R., and Robbins, R.A. (1997). Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery 121, 449-455.
21. Berman, B., and Smith, B. (1989). Trypsin inhibitors inhibit induction by interferon-γ of HLA-DR antigen expression in human skin cells. Exp. Cell Res. 183, 215-228.
22. Xu, X., Fu, X.Y., Plate, J., and Chong, A.S. (1998). IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of Stat1 protein for upregulation of Fas and FasL expression. Cancer Res. 58, 2832-2837.
23. Sukharev, S.A., Pleshakova, O.V., and Sadovnikov, V.B. (1997). Role of proteases in activation of apoptosis. Cell Death Differ. 4, 457-462.
24. Levi-Strumpf, N., and Kimchi, A. (1998). Death-associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 17, 3331-3340.
25. Wong, A.H., Durbin, J.E., Li, S., Dever, T.E., Decker, T., and Koromilas, A.E. (2001). Enhanced antiviral and antiproliferative properties of a Stat1 mutant unable to interact with the protein kinase PKR. J. Biol. Chem. 276, 13727-13737.
26. Asao, H., and Fu, X.Y. (2000). Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J. Biol. Chem. 275, 867-874.
27. Vihko, K.K., Sepanen, M., Henttinen, T., Punnonen, J., Grenman, S., and Punnonen, R. (1997). Regulation of proliferation of UM-SCV-6 vulvar carcinoma cells by cytokines. Cancer Immunol. Immunother. 43, 368-374.
28. Ruemmele, F.M., Gurbindo, C., Mansour, A.M., Marchand, R., Levy, E., and Seidman, E.G. (1998). Effects of IFN gamma on growth, apoptosis, and MHC class II expression of immature rat intestinal crypt (ICE-6) cells. J. Cell. Physiol. 176, 120-126.
29. Supria, P., Joshi, C.V., and Ajitkumar P. (1998). IFN-gamma inhibits growth of WISH cells in a cell cycle phase-specific manner. J. Interferon Cytokine Res. 18, 215-217.
30. Kominsky, S., Johnson, H.M., Bryan, G., Tanabe, T., Hobeika, A.C., Subramaniam, P.S., and TORRES, B. (1998). IFN gamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 17, 2973-2979.
31. Vivo, C., Levy, F., Pilatte, Y., Fleury-Feith, J., Chretien, P., Monnet, I., Kheuang, L., and Jaurand, M.C. (2001). Control of cell cycle progression in human mesothelioma cells treated with gamma interferon. Oncogene 20, 1085-1093.